We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$5.07B
AUM Growth
+$233M
Cap. Flow
+$256M
Cap. Flow %
5.04%
Top 10 Hldgs %
8.61%
Holding
1,586
New
113
Increased
363
Reduced
281
Closed
96

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$25.3M
2
HUM icon
Humana
HUM
+$22.7M
3
ALLY icon
Ally Financial
ALLY
+$21.8M
4
CL icon
Colgate-Palmolive
CL
+$21.4M
5
NEM icon
Newmont
NEM
+$20.4M

Sector Composition

Rank Sector Weight
1 Financials 20.89%
2 Industrials 13.68%
3 Healthcare 13.14%
4 Technology 11.02%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGI
1026
DELISTED
Celadon Group Inc
CGI
$554K 0.01%
26,800
HGG
1027
DELISTED
hhgregg Inc.
HGG
$553K 0.01%
165,500
-205,100
-55% -$980K
BCBP icon
1028
BCB Bancorp
BCBP
$172M
$552K 0.01%
45,200
MMS icon
1029
Maximus
MMS
$3.14B
$552K 0.01%
8,400
TBI
1030
Trueblue
TBI
$217M
$552K 0.01%
+18,450
New +$520K
AX icon
1031
Axos Financial
AX
$5.67B
$550K 0.01%
20,800
-2,000
-9% -$47.6K
EZPW icon
1032
Ezcorp Inc
EZPW
$1.84B
$549K 0.01%
73,900
MANH icon
1033
Manhattan Associates
MANH
$11.2B
$549K 0.01%
9,200
-900
-9% -$49.8K
BBSI icon
1034
Barrett Business Services
BBSI
$957M
$548K 0.01%
60,400
+7,200
+14% +$72.7K
RGLS
1035
DELISTED
Regulus Therapeutics
RGLS
$548K 0.01%
417
THOR
1036
DELISTED
THORATEC CORPORATION
THOR
$548K 0.01%
12,300
-1,200
-9% -$52.5K
USNA icon
1037
Usana Health Sciences
USNA
$408M
$547K 0.01%
8,000
-1,800
-18% -$114K
GLDC
1038
DELISTED
GOLDEN ENTERPRISES
GLDC
$547K 0.01%
+60,250
New +$243K
INFU icon
1039
InfuSystem Holdings
INFU
$187M
$546K 0.01%
171,278
CMPR icon
1040
Cimpress
CMPR
$2.34B
$545K 0.01%
6,475
-650
-9% -$55.5K
JASN
1041
DELISTED
Jason Industries, Inc.
JASN
$545K 0.01%
80,000
GDP
1042
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$545K 0.01%
292,900
+50,000
+21% +$156K
NTP
1043
DELISTED
Nam Tai Property Inc.
NTP
$545K 0.01%
113,100
WG
1044
DELISTED
Willbros Group
WG
$544K 0.01%
+425,000
New +$941K
TBHC
1045
DELISTED
The Brand House Collective
TBHC
$543K 0.01%
19,500
-23,700
-55% -$594K
STRR
1046
DELISTED
Star Equity Holdings
STRR
$543K 0.01%
2,500
ORRF icon
1047
Orrstown Financial Services
ORRF
$840M
$542K 0.01%
33,500
LOXO
1048
DELISTED
Loxo Oncology, Inc
LOXO
$541K 0.01%
+30,000
New +$410K
CHE icon
1049
Chemed
CHE
$7.09B
$538K 0.01%
4,100
-400
-9% -$49.5K
CRK icon
1050
Comstock Resources
CRK
$3.88B
$538K 0.01%
32,335
+15,795
+95% +$327K

Similar funds

Bridgeway Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Bridgeway Capital Management held 1,586 positions worth $5.07B, up 4.8% from $4.84B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Bridgeway Capital Management deployed $256M of net new capital in Q2 2015, opening 113 new positions and adding to 363 existing holdings. Its largest new stake was Humana: 122,463 shares worth $23.4M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $15.8M trimmed.

  • Bridgeway Capital Management's largest Q2 2015 buy was Humana: 122,463 shares worth $23.4M.
  • Bridgeway Capital Management added most to Johnson & Johnson in Q2 2015, an estimated $25.3M increase.
  • Bridgeway Capital Management's biggest Q2 2015 reduction was Amgen, cutting an estimated $15.8M.
  • Bridgeway Capital Management fully exited Alphabet (Google) Class C in Q2 2015, selling an estimated $24.7M.
  • Bridgeway Capital Management's ten largest holdings make up 8.6% of its $5.07B portfolio in Q2 2015.
  • Bridgeway Capital Management opened 113 new positions and closed 96 in Q2 2015.
  • Bridgeway Capital Management's portfolio value rose 4.8% quarter-over-quarter to $5.07B.

Based on Bridgeway Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.